tiprankstipranks
Trending News
More News >
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market
Advertisement

Inhibrx Biosciences Inc (INBX) Similar Stocks

Compare
24 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibrx Biosciences Inc
$27.40
$375.39M
0.20
93.09%
0 Buy
1 Hold
0 Sell
Hold
Prothena
$8.56
$449.48M
-59.94%
4 Buy
4 Hold
1 Sell
Moderate Buy
CytomX Therapeutics
$2.07
$334.77M
3.55
73.95%
4 Buy
1 Hold
0 Sell
Strong Buy
Humacyte
$1.53
$232.81M
-77.03%
6 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$4.67
$288.42M
13.61
-31.02%
3 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$5.91
$327.17M
0.51%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INBX
Inhibrx Biosciences Inc
27.40
13.44
96.28%
PRTA
Prothena
8.56
-12.69
-59.72%
CTMX
CytomX Therapeutics
2.07
0.91
78.45%
HUMA
Humacyte
1.53
-4.92
-76.28%
GLUE
Monte Rosa Therapeutics
4.67
-1.66
-26.22%
CADL
Candel Therapeutics
5.91
-0.36
-5.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis